BioCentury | Aug 29, 2005
Finance

Ebb & Flow

...as a venture partner. Previously, he was vice president of R&D at infectious disease play Elitra...
BioCentury | Nov 1, 2004
Company News

Myriad Genetics management update

...VP of chemistry at MYGN's Myriad Pharmaceuticals Inc. subsidiary, formerly director of medicinal chemistry at Elitra Pharmaceuticals Inc....
BioCentury | Sep 27, 2004
Company News

AlgoRx management update

...N.J. Business: Neurology Hired: Paul Hamelin as president and COO, formerly president and CEO of Elitra Pharmaceuticals Inc. WIR...
BioCentury | May 31, 2004
Product Development

Cracking antifungals

...has not borne much fruit," said Terry Roemer, director of fungal genomics and operations at Elitra Pharmaceuticals Inc....
...been a relatively limited number of targets to screen," Roemer said. To address these issues, Elitra...
...GRACE was the focus of Elitra's deal with Kaken Pharmaceutical Co. Ltd. to develop antifungals. Elitra...
BioCentury | Jun 30, 2003
Company News

Elitra management update

Elitra Pharmaceuticals Inc. , San Diego, Calif. Business: Infectious diseases Promoted: Paul Hamelin to CEO and a director, from COO, while remaining president; he replaces Harry Hixson, who remains chairman WIR Staff...
BioCentury | Jun 26, 2003
Company News

Elitra promotes Hamelin to CEO

...Antibacterial company Elitra (San Diego, Calif.) promoted Paul Hamelin to CEO and a director from COO...
BioCentury | Feb 24, 2003
Company News

Elitra, Kaken Pharmaceutical Co. Ltd. deal

...The companies partnered to develop anti-fungal therapeutics. Elitra will conduct high throughput screening against targets and...
...efforts. Kaken also will contribute to preclinical development, and both companies will coordinate clinical trials. Elitra...
...Elitra will receive a technology access payment and research funding, and is eligible for milestones. Elitra Pharmaceuticals Inc....
BioCentury | Jan 20, 2003
Company News

Sequenom board of directors update

...San Diego, Calif. Business: Diagnostics/Imaging, High throughput screening Appointed: Harry Hixson, chairman and CEO of Elitra Pharmaceuticals Inc. WIR...
BioCentury | Dec 9, 2002
Finance

Tracking Millennium's departures

...Predictive Medicine, which was formed in 1997 and acquired by MLNM in2000 Paul Hamelin 9/9/02 (Elitra...
BioCentury | Oct 21, 2002
Company News

Nereus management update

...diseases, Autoimmune/Inflammation Hired: Deborah Mosca as VP of research, formerly VP of drug development at Elitra Pharmaceuticals Inc. WIR...
Items per page:
1 - 10 of 42
BioCentury | Aug 29, 2005
Finance

Ebb & Flow

...as a venture partner. Previously, he was vice president of R&D at infectious disease play Elitra...
BioCentury | Nov 1, 2004
Company News

Myriad Genetics management update

...VP of chemistry at MYGN's Myriad Pharmaceuticals Inc. subsidiary, formerly director of medicinal chemistry at Elitra Pharmaceuticals Inc....
BioCentury | Sep 27, 2004
Company News

AlgoRx management update

...N.J. Business: Neurology Hired: Paul Hamelin as president and COO, formerly president and CEO of Elitra Pharmaceuticals Inc. WIR...
BioCentury | May 31, 2004
Product Development

Cracking antifungals

...has not borne much fruit," said Terry Roemer, director of fungal genomics and operations at Elitra Pharmaceuticals Inc....
...been a relatively limited number of targets to screen," Roemer said. To address these issues, Elitra...
...GRACE was the focus of Elitra's deal with Kaken Pharmaceutical Co. Ltd. to develop antifungals. Elitra...
BioCentury | Jun 30, 2003
Company News

Elitra management update

Elitra Pharmaceuticals Inc. , San Diego, Calif. Business: Infectious diseases Promoted: Paul Hamelin to CEO and a director, from COO, while remaining president; he replaces Harry Hixson, who remains chairman WIR Staff...
BioCentury | Jun 26, 2003
Company News

Elitra promotes Hamelin to CEO

...Antibacterial company Elitra (San Diego, Calif.) promoted Paul Hamelin to CEO and a director from COO...
BioCentury | Feb 24, 2003
Company News

Elitra, Kaken Pharmaceutical Co. Ltd. deal

...The companies partnered to develop anti-fungal therapeutics. Elitra will conduct high throughput screening against targets and...
...efforts. Kaken also will contribute to preclinical development, and both companies will coordinate clinical trials. Elitra...
...Elitra will receive a technology access payment and research funding, and is eligible for milestones. Elitra Pharmaceuticals Inc....
BioCentury | Jan 20, 2003
Company News

Sequenom board of directors update

...San Diego, Calif. Business: Diagnostics/Imaging, High throughput screening Appointed: Harry Hixson, chairman and CEO of Elitra Pharmaceuticals Inc. WIR...
BioCentury | Dec 9, 2002
Finance

Tracking Millennium's departures

...Predictive Medicine, which was formed in 1997 and acquired by MLNM in2000 Paul Hamelin 9/9/02 (Elitra...
BioCentury | Oct 21, 2002
Company News

Nereus management update

...diseases, Autoimmune/Inflammation Hired: Deborah Mosca as VP of research, formerly VP of drug development at Elitra Pharmaceuticals Inc. WIR...
Items per page:
1 - 10 of 42